Pekka Taimen

Value of 68Ga-labeled bombesin antagonist (RM2) in the detection of primary prostate cancer comparing with [18F]fluoromethylcholine PET-CT and multiparametric MRI—a phase I/II study (2022)

European Radiology

Beheshti Mohsen, Taimen Pekka, Kemppainen Jukka, Jambor Ivan, Mueller Andre, Loidl Wolfgang, Kähkönen Esa, Käkelä Meeri, Berndt Mathias, Stephens Andrew W., Minn Heikki, Langsteger Werner

(Vertaisarvioitu alkuperäisartikkeli tai data-artikkeli tieteellisessä aikakauslehdessä (A1))

PP2A methylesterase PME-1 suppresses anoikis and is associated with therapy relapse of PTEN-deficient prostate cancers (2022)

Molecular Oncology

Aakula Anna, Isomursu Aleksi, Rupp Christian, Erickson Andrew, Gupta Nikhil, Kauko Otto, Shah Pragya, Padzik Artur, Pokharel Yuba Raj, Kaur Amanpreet, Li Song-Ping, Trotman Lloyd, Taimen Pekka, Rannikko Antti, Lammerding Jan, Paatero Ilkka, Mirtti Tuomas, Ivaska Johanna, Westermarck Jukka

(Vertaisarvioitu alkuperäisartikkeli tai data-artikkeli tieteellisessä aikakauslehdessä (A1))

Individualised non-contrast MRI-based risk estimation and shared decision-making in men with a suspicion of prostate cancer: protocol for multicentre randomised controlled trial (multi-IMPROD V.2.0) (2022)

BMJ Open

Ettala Otto, Jambor Ivan, Perez Ileana Montoya, Seppänen Marjo, Kaipia Antti, Seikkula Heikki, Syvänen Kari T, Taimen Pekka, Verho Janne, Steiner Aida, Saunavaara Jani, Saukko Ekaterina, Löyttyniemi Eliisa, Sjoberg Daniel D, Vickers Andrew, Aronen Hannu, Boström Peter

(Vertaisarvioitu alkuperäisartikkeli tai data-artikkeli tieteellisessä aikakauslehdessä (A1))

Evolving imaging methods of prostate cancer and the emergence of magnetic resonance imaging guided ablation techniques (2022)

Frontiers in Oncology

Anttinen Mikael, Sequeiros Roberto Blanco, Boström Peter J, Taimen Pekka

(Vertaisarvioitu alkuperäisartikkeli tai data-artikkeli tieteellisessä aikakauslehdessä (A1))

The variant rs77559646 associated with aggressive prostate cancer disrupts ANO7 mRNA splicing and protein expression (2022)

Human Molecular Genetics

Wahlström Gudrun, Heron Samuel, Knuuttila Matias, Kaikkonen Elina, Tulonen Nea, Metsälä Olli, Lof Christoffer, Ettala Otto, Boström Peter J., Taimen Pekka, Poutanen Matti, Schleutker Johanna

(Vertaisarvioitu alkuperäisartikkeli tai data-artikkeli tieteellisessä aikakauslehdessä (A1))

A heterozygous p.S143P mutation in LMNA associates with proteasome dysfunction and enhanced autophagy-mediated degradation of mutant lamins A and C (2022)

Frontiers in cell and developmental biology

West Gun, Turunen Minttu, Aalto Anna, Virtanen Laura, Li Song-Ping, Heliö Tiina, Meinander Annika, Taimen Pekka

(Vertaisarvioitu alkuperäisartikkeli tai data-artikkeli tieteellisessä aikakauslehdessä (A1))

Predicting the Need for Biopsy to Detect Clinically Significant Prostate Cancer in Patients with a Magnetic Resonance Imaging–detected Prostate Imaging Reporting and Data System/Likert ≥3 Lesion: Development and Multinational External Validation of the Imperial Rapid Access to Prostate Imaging and Diagnosis Risk Score (2022)

European Urology

Peters Max, Eldred-Evans David, Kurver Piet, Falagario Ugo Giovanni, Connor Martin J., Shah Taimur T., Verhoeff Joost J.C., Taimen Pekka, Aronen Hannu J., Knaapila Juha, Montoya Perez Ileana, Ettala Otto, Stabile Armando, Gandaglia Giorgio, Fossati Nicola, Martini Alberto, Cucchiara Vito, Briganti Alberto, Lantz Anna, Picker Wolfgang, Haug Erik Skaaheim, Nordström Tobias, Tanaka Mariana Bertoncelli, Reddy Deepika, Bass Edward, van Rossum Peter S.N., Wong Kathie, Tam Henry, Winkler Mathias, Gordon Stephen, Qazi Hasan, Boström Peter J., Jambor Ivan, Ahmed Hashim U.

(A1 Vertaisarvioitu alkuperäisartikkeli tieteellisessä lehdessä )

Test-retest repeatability of a deep learning architecture in detecting and segmenting clinically significant prostate cancer on apparent diffusion coefficient (ADC) maps (2021)

European Radiology

Hiremath Amogh, Shiradkar Rakesh, Merisaari Harri, Prasanna Prateek, Ettala Otto, Taimen Pekka, Aronen Hannu J, Boström Peter J, Jambor Ivan, Madabhushi Anant

(Vertaisarvioitu alkuperäisartikkeli tai data-artikkeli tieteellisessä aikakauslehdessä (A1))

Accurate Prostate Cancer Detection and Segmentation Using Non-Local Mask R-CNN With Histopathological Ground Truth (2021)

International Journal of Radiation Oncology - Biology - Physics

Dai Z, Jambor I, Taimen P, Pantelic M, Elshaikh MA, Dabaja A, Rogers C, Ettala O, Bostrom P, Aronen H, Merisaari H, Wen N

(O2 Muu julkaisu )

Combined Use of Prostate-specific Antigen Density and Magnetic Resonance Imaging for Prostate Biopsy Decision Planning: A Retrospective Multi-institutional Study Using the Prostate Magnetic Resonance Imaging Outcome Database (PROMOD). (2021)

European Urology Oncology

Falagario UG, Jambor I, Lantz A, Ettala O, Stabile A, Taimen P, Aronen HJ, Knaapila J, Perez IM, Gandaglia G, Fossati N, Martini A, Cucchiara V, Picker W, Haug E, Haines K, Ratnani P, Sujit N, Lewis S, Sanguedolce F, Selvaggio O, Cormio L, Macarini L, Tewari A, Nordström T, Boström PJ, Briganti A, Carrieri G

(Vertaisarvioitu alkuperäisartikkeli tai data-artikkeli tieteellisessä aikakauslehdessä (A1))

Ota yhteyttä

Linkit

Julkaisut

Järjestä:

Value of 68Ga-labeled bombesin antagonist (RM2) in the detection of primary prostate cancer comparing with [18F]fluoromethylcholine PET-CT and multiparametric MRI—a phase I/II study (2022)

PP2A methylesterase PME-1 suppresses anoikis and is associated with therapy relapse of PTEN-deficient prostate cancers (2022)

Individualised non-contrast MRI-based risk estimation and shared decision-making in men with a suspicion of prostate cancer: protocol for multicentre randomised controlled trial (multi-IMPROD V.2.0) (2022)

Evolving imaging methods of prostate cancer and the emergence of magnetic resonance imaging guided ablation techniques (2022)

The variant rs77559646 associated with aggressive prostate cancer disrupts ANO7 mRNA splicing and protein expression (2022)

A heterozygous p.S143P mutation in LMNA associates with proteasome dysfunction and enhanced autophagy-mediated degradation of mutant lamins A and C (2022)

Test-retest repeatability of a deep learning architecture in detecting and segmenting clinically significant prostate cancer on apparent diffusion coefficient (ADC) maps (2021)

Accurate Prostate Cancer Detection and Segmentation Using Non-Local Mask R-CNN With Histopathological Ground Truth (2021)

Combined Use of Prostate-specific Antigen Density and Magnetic Resonance Imaging for Prostate Biopsy Decision Planning: A Retrospective Multi-institutional Study Using the Prostate Magnetic Resonance Imaging Outcome Database (PROMOD). (2021)